Introducing Our Team
Esya’s mission is the early, precise, and cost-effective detection of neurodegenerative diseases. Initially supporting pharma company’s drug discovery and personalised medicine development. Eventually Esya’s core diagnostics product will be the world’s first blood test for early detection of Lysosomal disorders
Dhivya Venkat - Chief Executive Officer and Co-Founder
An Entrepreneur having worked with startups and multibillion business enterprises, focusing on building best in class teams to deliver results. An international strategy consultant with expertise working in over 49 countries, alongside global consultancy houses Accenture, Deloitte and some of the world’s leading Financial institutions, bring new products to market and growing EBITDA
Dr.Yamuna Krishnan - Chief Science Officer and Co-founder
Professor of Chemistry and Brain Research Foundation Fellow, University of Chicago. Pioneered the application of DNA nanotechnology to live imaging through ground breaking academic research in world-class institutions. Known for innovative approaches to scientific problems. Has won numerous prestigious awards with multiple publications in peer-reviewed journals internationally
Frank Kondrad - Head of Commercial
A science-based business leader with a broad 40-year healthcare leadership background. Frank has led new drug and device product strategy, clinical development, business development in/out-licensing, commercial brand and payer marketing and research, corporate strategic planning and chemistry, manufacturing and control.
Don Dwyer - Head of Business Development
A science-based business leader with over 30 years of experience in the biopharmaceutical industry and broad background in leadership across a wide range of technologies and disease areas. Don has held director level positions in quality assurance/control and regulatory affairs (Rhone-Poulenc Rorer and Cephalon); and drug development, commercialization and business development (AstraZeneca).
Kasturi Chakrabothy - Director of Clinical Studies
Aditya Shekhar - Director of Brand and Marketing
Aditya Shekhar is an experienced biomedical researcher and brand strategist. He has contributed to over twenty publications in peer-reviewed medical journals and given presentations at several major medical conferences.
Associate Research Scientist at Institute of Physical Sciences & Technology (University of Maryland). Extensive experience with optical probes development, characterization and application, both in vitro and in vivo at the forefronts of Data Science and Machine Learning enthusiast. Expert in biological fluorescence, ultra-fast laser microscopy and super-resolution imaging.
More than 20 years of pharmaceutical industry leadership experience, including roles at AstraZeneca, Roche, HBA and WPIC. She brings a wealth of experience in US and Europe through working in clinical development, global strategic marketing, business development, licensing and M&A.
Expert knowledge with the current principal manual for psychiatric & neurocognitive diagnosis, recommended by the American Psychiatric Association. For more than 35 years, Dr. Kupfer’s work has focused on the conceptualization, diagnosis and treatment of mood disorders.
Founded and built Marathon Pharmaceuticals and on the board of Perora Diagnostics. Precious experience spans commercialization, product and clinical development, medical affairs, RA/QA, compliance, manufacturing, life-cycle management and highly successful strategic partnerships.
Demonstrated record of excellence in negotiating complex deals including; technology, patent and know-how licensing (in/out); companion diagnostic/personalized medicine deals, supply and third party manufacturing deals, settlements and acquisition and divestiture activities.
Jamie has brought more than 70 programs from Discovery to Development, leading and supporting efforts through all phases, including the launches of 8 commercial products. Jamie is committed to translating cutting edge science into actual medicines that positively impact people